News & Insights
Knowing that patients’ lives will be transformed, pursuing cell therapy commercialization is exciting and filled with hope. But the path to approval is also littered with hidden pitfalls. Even the most innovative therapies can be delayed or derailed by avoidable CMC issues.
This infographic from Kincell Bio highlights 12 of the most common CMC challenges that developers face, from assay gaps and raw material risks to regulatory misalignment and facility readiness. Whether you’re preparing an IND, scaling your process, or optimizing for GMP, this resource offers a clear, visual roadmap to help your team stay ahead of risk and accelerate development.
At Kincell Bio, we’ve seen these challenges firsthand, and we’ve built our processes, teams, and facilities to help you avoid them.
Download and share the infographic to start a conversation with your team, and let’s work together to future-proof your cell therapy program.
